{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:27:32Z","timestamp":1794414452250,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41433-026-04827-0","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:58:56Z","timestamp":1789477136000},"page":"2546-2555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geometric and concavity characteristics as diagnostic markers for differentiating nAMD-related MNV from pachychoroid neovascularisation"],"prefix":"10.1038","volume":"40","author":[{"given":"Jiaxin","family":"Pu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuenan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyue","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"4827_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.survophthal.2024.08.003","volume":"70","author":"JU Sheth","year":"2025","unstructured":"Sheth JU, Stewart MW, Narayanan R, Anantharaman G, Chandran K, Lai TYY, et al. Macular neovascularization. Surv Ophthalmol. 2025;70:653\u201375. https:\/\/doi.org\/10.1016\/j.survophthal.2024.08.003.","journal-title":"Surv Ophthalmol"},{"key":"4827_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology. 2020;127:616\u201336. https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.004.","journal-title":"Ophthalmology"},{"key":"4827_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.22608\/apo.2017260","volume":"6","author":"GCM Cheung","year":"2017","unstructured":"Cheung GCM, Lai TYY, Gomi F, Ruamviboonsuk P, Koh A, Lee WK. Anti-VEGF therapy for neovascular AMD and polypoidal choroidal vasculopathy. Asia Pac J Ophthalmol. 2017;6:527\u201334. https:\/\/doi.org\/10.22608\/apo.2017260.","journal-title":"Asia Pac J Ophthalmol"},{"key":"4827_CR4","doi-asserted-by":"publisher","first-page":"e0212055","DOI":"10.1371\/journal.pone.0212055","volume":"14","author":"K Azuma","year":"2019","unstructured":"Azuma K, Tan X, Asano S, Shimizu K, Ogawa A, Inoue T, et al. The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy. PLoS ONE. 2019;14:e0212055 https:\/\/doi.org\/10.1371\/journal.pone.0212055.","journal-title":"PLoS ONE"},{"key":"4827_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.survophthal.2024.12.004","volume":"70","author":"A Servillo","year":"2025","unstructured":"Servillo A, Scandale P, Oldoni G, Begar PG, Bandello F, Miserocchi E, et al. Inflammatory choroidal neovascularization: an evidence-based update. Surv Ophthalmol. 2025;70:451\u201366. https:\/\/doi.org\/10.1016\/j.survophthal.2024.12.004.","journal-title":"Surv Ophthalmol"},{"key":"4827_CR6","doi-asserted-by":"publisher","first-page":"s3","DOI":"10.1016\/j.ophtha.2013.01.057","volume":"120","author":"JA Haller","year":"2013","unstructured":"Haller JA. Current anti-vascular endothelial growth factor dosing regimens: benefits and burden. Ophthalmology. 2013;120:s3\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2013.01.057.","journal-title":"Ophthalmology"},{"key":"4827_CR7","doi-asserted-by":"publisher","first-page":"e0248760","DOI":"10.1371\/journal.pone.0248760","volume":"16","author":"A Miki","year":"2021","unstructured":"Miki A, Kusuhara S, Otsuji T, Kawashima Y, Miki K, Imai H, et al. Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. PLoS ONE. 2021;16:e0248760 https:\/\/doi.org\/10.1371\/journal.pone.0248760.","journal-title":"PLoS ONE"},{"key":"4827_CR8","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1038\/s41433-021-01418-z","volume":"35","author":"T Hikichi","year":"2021","unstructured":"Hikichi T, Kubo N, Yamauchi M. One-year comparison of anti-vascular endothelial growth factor and half-dose photodynamic therapies for pachychoroid neovasculopathy. Eye. 2021;35:3367\u201375. https:\/\/doi.org\/10.1038\/s41433-021-01418-z.","journal-title":"Eye"},{"key":"4827_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/iae.0000000000000809","volume":"36","author":"JH Lee","year":"2016","unstructured":"Lee JH, Lee WK. One-year results of adjunctive photodynamic therapy for type 1 neovascularization associated with thickened choroid. Retina. 2016;36:889\u201395. https:\/\/doi.org\/10.1097\/iae.0000000000000809.","journal-title":"Retina"},{"key":"4827_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65346-w","volume":"10","author":"K Azuma","year":"2020","unstructured":"Azuma K, Okubo A, Nomura Y, Zhou H, Terao R, Hashimoto Y, et al. Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy. Sci Rep. 2020;10:8337. https:\/\/doi.org\/10.1038\/s41598-020-65346-w.","journal-title":"Sci Rep"},{"key":"4827_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91589-2","volume":"11","author":"J Yoon","year":"2021","unstructured":"Yoon J, Yoon W, Na SK, Lee J, Kim CG, Kim JW, et al. Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy. Sci Rep. 2021;11:12052. https:\/\/doi.org\/10.1038\/s41598-021-91589-2.","journal-title":"Sci Rep"},{"key":"4827_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33936-z","volume":"13","author":"A Kuranami","year":"2023","unstructured":"Kuranami A, Maruko R, Maruko I, Hasegawa T, Iida T. Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration. Sci Rep. 2023;13:7379. https:\/\/doi.org\/10.1038\/s41598-023-33936-z.","journal-title":"Sci Rep"},{"key":"4827_CR13","doi-asserted-by":"publisher","first-page":"amd160","DOI":"10.1167\/iovs.18-24882","volume":"59","author":"CA Curcio","year":"2018","unstructured":"Curcio CA. Soft drusen in age-related macular degeneration: biology and targeting via the oil spill strategies. Invest Ophthalmol Vis Sci. 2018;59:amd160\u2013amd181. https:\/\/doi.org\/10.1167\/iovs.18-24882.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4827_CR14","first-page":"2955","volume":"64","author":"CA Curcio","year":"2023","unstructured":"Curcio CA, Messinger JD, Balaratnasingam C, Mendis R, Ferrara D, Freund B, et al. Histology of cells suggestive of inflammation in treated neovascular age-related macular degeneration (AMD), a clinicopathologic correlation. Invest Ophthalmol Vis Sci. 2023;64:2955.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4827_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-vision-102122-102907","volume":"10","author":"AH Khan","year":"2024","unstructured":"Khan AH, Lotery AJ. Central serous chorioretinopathy: epidemiology, genetics and clinical features. Annu Rev Vis Sci. 2024;10:477\u2013505. https:\/\/doi.org\/10.1146\/annurev-vision-102122-102907.","journal-title":"Annu Rev Vis Sci"},{"key":"4827_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101372","volume":"107","author":"P Viggiano","year":"2025","unstructured":"Viggiano P, Boscia G, Sadeghi E, Cheung G, Borrelli E, Alessio G, et al. Pachychoroid disease spectrum: how multimodal imaging and OCTA angiography have improved our knowledge. Prog Retin Eye Res. 2025;107:101372. https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101372.","journal-title":"Prog Retin Eye Res"},{"key":"4827_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41433-024-03587-z","volume":"39","author":"P Viggiano","year":"2025","unstructured":"Viggiano P, Demirel S, Petruzzella G, Pignataro M, Boscia G, Clemente A, et al. Choriocapillaris flow in two different patterns of exudative type 1 macular neovascularization. Eye. 2025;39:556\u201362. https:\/\/doi.org\/10.1038\/s41433-024-03587-z.","journal-title":"Eye"},{"key":"4827_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.preteyeres.2017.07.002","volume":"60","author":"AH Kashani","year":"2017","unstructured":"Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66\u2013100. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.07.002.","journal-title":"Prog Retin Eye Res"},{"key":"4827_CR19","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41433-024-03007-2","volume":"38","author":"\u00d6 Yan\u0131k","year":"2024","unstructured":"Yan\u0131k \u00d6, Demirel S, \u00d6zcan G, Bat\u0131o\u011flu F, \u00d6zmert E. Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography. Eye. 2024;38:1714\u201321. https:\/\/doi.org\/10.1038\/s41433-024-03007-2.","journal-title":"Eye"},{"key":"4827_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46891-6","volume":"13","author":"H Riazi-Esfahani","year":"2023","unstructured":"Riazi-Esfahani H, Asadi Khameneh E, Ghassemi F, Mehrabi Bahar M, Torkashvand A, Mahmoudi A, et al. Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment. Sci Rep. 2023;13:19513. https:\/\/doi.org\/10.1038\/s41598-023-46891-6.","journal-title":"Sci Rep"},{"key":"4827_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.18502\/jovr.v16i2.9091","volume":"16","author":"P Anvari","year":"2021","unstructured":"Anvari P, Ashrafkhorasani M, Habibi A, Falavarjani KG. Artifacts in optical coherence tomography angiography. J Ophthalmic Vis Res. 2021;16:271\u201386. https:\/\/doi.org\/10.18502\/jovr.v16i2.9091.","journal-title":"J Ophthalmic Vis Res"},{"key":"4827_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ophtha.2018.11.020","volume":"126","author":"E Daniel","year":"2019","unstructured":"Daniel E, Ying GS, Kim BJ, Toth CA, Ferris F 3rd, Martin DF, et al. Follow up at 5 years of non-fibrotic scars in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2019;126:743\u201351. https:\/\/doi.org\/10.1016\/j.ophtha.2018.11.020.","journal-title":"Ophthalmology"},{"key":"4827_CR23","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.2147\/opth.s327138","volume":"15","author":"Y Matsuo","year":"2021","unstructured":"Matsuo Y, Haruta M, Ishibashi Y, Ishibashi K, Furushima K, Kato N, et al. Visual outcomes and prognostic factors of large submacular hemorrhages secondary to polypoidal choroidal vasculopathy. Clin Ophthalmol. 2021;15:3557\u201362. https:\/\/doi.org\/10.2147\/opth.s327138.","journal-title":"Clin Ophthalmol"},{"key":"4827_CR24","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4103\/ijo.ijo_1987_22","volume":"71","author":"SK Boral","year":"2023","unstructured":"Boral SK, Agarwal D, Das A, Chakraborty D, Mandal S. Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages. Indian J Ophthalmol. 2023;71:2045\u201352. https:\/\/doi.org\/10.4103\/ijo.ijo_1987_22.","journal-title":"Indian J Ophthalmol"},{"key":"4827_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2024.06.019","volume":"267","author":"J Pu","year":"2024","unstructured":"Pu J, Zhuang X, Li M, Zhang X, Su Y, He G, et al. Analyzing formation and absorption of avascular subretinal hyperreflective material in nAMD from OCTA-based insights. Am J Ophthalmol. 2024;267:192\u2013203. https:\/\/doi.org\/10.1016\/j.ajo.2024.06.019.","journal-title":"Am J Ophthalmol"},{"key":"4827_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/bjo-2024-326319","volume":"109","author":"J Pu","year":"2025","unstructured":"Pu J, Zhuang X, Li M, Hao X, He G, Su Y, et al. Prognostic value of macular neovascularisation characteristics for photoreceptor integrity in nAMD: a prospective observational study. Br J Ophthalmol. 2025;109:689\u201396. https:\/\/doi.org\/10.1136\/bjo-2024-326319.","journal-title":"Br J Ophthalmol"},{"key":"4827_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/bjo-2025-327339","volume":"110","author":"J Pu","year":"2025","unstructured":"Pu J, Zhuang X, Li M, Zhang X, Ji Y, Mi L, et al. Association between early lesion response and long-term anti-VEGF injection frequency in nAMD: a 2-year prospective study using 3D volumetric analysis. Br J Ophthalmol. 2025;110:67\u201375. https:\/\/doi.org\/10.1136\/bjo-2025-327339.","journal-title":"Br J Ophthalmol"},{"key":"4827_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.14.10.1","volume":"14","author":"J Pu","year":"2025","unstructured":"Pu J, Zhuang X, Li M, Hao X, He G, Su Y, et al. Early fluctuations of exudative lesions as predictors of two-year clinical outcomes in neovascular age-related macular degeneration. Transl Vis Sci Technol. 2025;14:1 https:\/\/doi.org\/10.1167\/tvst.14.10.1.","journal-title":"Transl Vis Sci Technol"},{"key":"4827_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep16204","volume":"5","author":"M Miyake","year":"2015","unstructured":"Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204. https:\/\/doi.org\/10.1038\/srep16204.","journal-title":"Sci Rep"},{"key":"4827_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","volume":"4","author":"J Chhablani","year":"2020","unstructured":"Chhablani J, Cohen FB. Central Serous Chorioretinopathy International Group. Multimodal imaging-based central serous chorioretinopathy classification. Ophthalmol Retina. 2020;4:1043\u20136. https:\/\/doi.org\/10.1016\/j.oret.2020.07.026.","journal-title":"Ophthalmol Retina"},{"key":"4827_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2018.06.009","volume":"193","author":"C Shiragami","year":"2018","unstructured":"Shiragami C, Takasago Y, Osaka R, Kobayashi M, Ono A, Yamashita A, et al. Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization. Am J Ophthalmol. 2018;193:80\u201386. https:\/\/doi.org\/10.1016\/j.ajo.2018.06.009.","journal-title":"Am J Ophthalmol"},{"key":"4827_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/iae.0000000000002810","volume":"41","author":"MC Savastano","year":"2021","unstructured":"Savastano MC, Rispoli M, Lumbroso B. The incidence of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography. Retina. 2021;41:302\u20138. https:\/\/doi.org\/10.1097\/iae.0000000000002810.","journal-title":"Retina"},{"key":"4827_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.64.11.25","volume":"64","author":"G He","year":"2023","unstructured":"He G, Zhang X, Gan Y, Li M, Zhuang X, Zeng Y, et al. Choroidal vein alterations in pachychoroid disease with choroidal vascular hyperpermeability: evaluated by wide-field indocyanine green angiography. Invest Ophthalmol Vis Sci. 2023;64:25 https:\/\/doi.org\/10.1167\/iovs.64.11.25.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4827_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2024.104358","volume":"50","author":"X Hao","year":"2024","unstructured":"Hao X, He G, Li M, Pu J, Zhuang X, Su Y, et al. Widefield indocyanine green angiography evaluating choroidal vein drainage pattern and choroidal vein alterations in acute and chronic central serous chorioretinopathy. Photodiagnosis Photodyn Ther. 2024;50:104358. https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104358.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4827_CR35","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/bjophthalmol-2018-313065","volume":"103","author":"F Coscas","year":"2019","unstructured":"Coscas F, Lupidi M, Boulet JF, Sellam A, Cabral D, Serra R, et al. Optical coherence tomography angiography in exudative age-related macular degeneration: a predictive model for treatment decisions. Br J Ophthalmol. 2019;103:1342\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313065.","journal-title":"Br J Ophthalmol"},{"key":"4827_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97652-2","volume":"11","author":"CR Hsu","year":"2021","unstructured":"Hsu CR, Lai TT, Hsieh YT, Ho TC, Yang CM, Yang CH. Combined quantitative and qualitative optical coherence tomography angiography biomarkers for predicting active neovascular age-related macular degeneration. Sci Rep. 2021;11:18068. https:\/\/doi.org\/10.1038\/s41598-021-97652-2.","journal-title":"Sci Rep"},{"key":"4827_CR37","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.18240\/ijo.2022.11.15","volume":"15","author":"SM Ahn","year":"2022","unstructured":"Ahn SM, Choi M, Yun C, Kim SW, Oh J. Changes on optical coherence tomography angiography and fluorescein angiography in eyes with neovascular age-related macular degeneration. Int J Ophthalmol. 2022;15:1837\u201344. https:\/\/doi.org\/10.18240\/ijo.2022.11.15.","journal-title":"Int J Ophthalmol"},{"key":"4827_CR38","doi-asserted-by":"publisher","first-page":"e0205513","DOI":"10.1371\/journal.pone.0205513","volume":"13","author":"F Coscas","year":"2018","unstructured":"Coscas F, Cabral D, Pereira T, Geraldes C, Narotamo H, Miere A, et al. Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission. PLoS ONE. 2018;13:e0205513 https:\/\/doi.org\/10.1371\/journal.pone.0205513.","journal-title":"PLoS ONE"},{"key":"4827_CR39","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/1120672120925790","volume":"31","author":"E Ozdemir Zeydanli","year":"2021","unstructured":"Ozdemir Zeydanli E, Gurelik G. Optical coherence tomography angiography markers associated with treatment response in neovascular age-related macular degeneration. Eur J Ophthalmol. 2021;31:1192\u20131200. https:\/\/doi.org\/10.1177\/1120672120925790.","journal-title":"Eur J Ophthalmol"},{"key":"4827_CR40","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.18240\/ijo.2025.08.10","volume":"18","author":"YM Shi","year":"2025","unstructured":"Shi YM, Xie X, Wang WQ, Yuan XM, Zhang ZP, Wang HY, et al. Quantitative characterization of types 1 and 2 macular neovascularization in neovascular age-related macular degeneration with intravitreal conbercept: an analysis utilizing optical coherence tomography angiography. Int J Ophthalmol. 2025;18:1490\u20137. https:\/\/doi.org\/10.18240\/ijo.2025.08.10.","journal-title":"Int J Ophthalmol"},{"key":"4827_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/tvst.9.3.18","volume":"9","author":"D Cabral","year":"2020","unstructured":"Cabral D, Coscas F, Pereira T, Fran\u00e7ais C, Geraldes C, Laiginhas R, et al. Quantitative optical coherence tomography angiography biomarkers in a treat-and-extend dosing regimen in neovascular age-related macular degeneration. Transl Vis Sci Technol. 2020;9:18 https:\/\/doi.org\/10.1167\/tvst.9.3.18.","journal-title":"Transl Vis Sci Technol"},{"key":"4827_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28484-w","volume":"8","author":"N Terao","year":"2018","unstructured":"Terao N, Koizumi H, Kojima K, Yamagishi T, Yamamoto Y, Yoshii K, et al. Distinct aqueous humour cytokine profiles of patients with pachychoroid neovasculopathy and neovascular age-related macular degeneration. Sci Rep. 2018;8:10520. https:\/\/doi.org\/10.1038\/s41598-018-28484-w.","journal-title":"Sci Rep"},{"key":"4827_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1167\/iovs.16-20967","volume":"58","author":"M Hata","year":"2017","unstructured":"Hata M, Yamashiro K, Ooto S, Oishi A, Tamura H, Miyata M, et al. Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2017;58:292\u20138. https:\/\/doi.org\/10.1167\/iovs.16-20967.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4827_CR44","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.ophtha.2015.03.005","volume":"122","author":"I Lengyel","year":"2015","unstructured":"Lengyel I, Csutak A, Florea D, Leung I, Bird AC, Jonasson F, et al. A population-based ultra-widefield digital image grading study for age-related macular degeneration-like lesions at the peripheral retina. Ophthalmology. 2015;122:1340\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.005.","journal-title":"Ophthalmology"},{"key":"4827_CR45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/ceo.13306","volume":"46","author":"L Chen","year":"2018","unstructured":"Chen L, Zhang X, Liu B, Mi L, Wen F. Age-related scattered hypofluorescent spots on late-phase indocyanine green angiography: the multimodal imaging and relevant factors. Clin Exp Ophthalmol. 2018;46:908\u201315. https:\/\/doi.org\/10.1111\/ceo.13306.","journal-title":"Clin Exp Ophthalmol"},{"key":"4827_CR46","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1167\/iovs.18-25124","volume":"59","author":"L Chen","year":"2018","unstructured":"Chen L, Zhang X, Li M, Gan Y, Wen F. Drusen and age-related scattered hypofluorescent spots on late-phase indocyanine green angiography, a candidate correlate of lipid accumulation. Invest Ophthalmol Vis Sci. 2018;59:5237\u201345. https:\/\/doi.org\/10.1167\/iovs.18-25124.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4827_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101414","volume":"110","author":"Z Yang","year":"2026","unstructured":"Yang Z, Zhang W, Gu X, Zhao X, Sadda SR, Cheung G, et al. Polypoidal choroidal vasculopathy: In-depth insights and promising future directions. Prog Retin Eye Res. 2026;110:101414. https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101414.","journal-title":"Prog Retin Eye Res"},{"key":"4827_CR48","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, et al. Polypoidal choroidal vasculopathy: Consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV workgroup. Ophthalmology. 2021;128:443\u201352. https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.006.","journal-title":"Ophthalmology"},{"key":"4827_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.oret.2022.04.004","volume":"6","author":"J Siedlecki","year":"2022","unstructured":"Siedlecki J, Klaas JE, Keidel LF, Asani B, Luft N, Priglinger SG, et al. Progression of pachychoroid neovasculopathy into aneurysmal type 1 choroidal neovascularization or polypoidal choroidal vasculopathy. Ophthalmol Retina. 2022;6:807\u201313. https:\/\/doi.org\/10.1016\/j.oret.2022.04.004.","journal-title":"Ophthalmol Retina"},{"key":"4827_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/IAE.0000000000001628","volume":"38","author":"M Al-Sheikh","year":"2018","unstructured":"Al-Sheikh M, Iafe NA, Phasukkijwatana N, Sadda SR, Sarraf D. Biomarkers of neovascular activity in age-related macular degeneration using OCT angiography. Retina. 2018;38:220\u201330.","journal-title":"Retina"},{"key":"4827_CR51","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1111\/aos.15219","volume":"101","author":"M Schranz","year":"2023","unstructured":"Schranz M, Told R, Hacker V, Reiter GS, Reumueller A, Vogl WD, et al. Correlation of vascular and fluid-related parameters in neovascular age-related macular degeneration using deep learning. Acta Ophthalmol. 2023;101:e95\u2013e105. https:\/\/doi.org\/10.1111\/aos.15219.","journal-title":"Acta Ophthalmol"},{"key":"4827_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ajo.2020.01.012","volume":"213","author":"M Choi","year":"2020","unstructured":"Choi M, Kim SW, Yun C, Oh J. OCT angiography features of neovascularization as predictive factors for frequent recurrence in age-related macular degeneration. Am J Ophthalmol. 2020;213:109\u201319. https:\/\/doi.org\/10.1016\/j.ajo.2020.01.012.","journal-title":"Am J Ophthalmol"},{"key":"4827_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00417-020-04844-z","volume":"259","author":"EHC van Dijk","year":"2021","unstructured":"van Dijk EHC, Mohabati D, Veselinovic S, Chung WH, Dijkman G, Boon CJF. The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification. Graefes Arch Clin Exp Ophthalmol. 2021;259:351\u201361. https:\/\/doi.org\/10.1007\/s00417-020-04844-z.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4827_CR54","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.oret.2025.04.019","volume":"9","author":"MJ Sirks","year":"2025","unstructured":"Sirks MJ, van Dijk EHC, Ghalayini H, Bazdar S, Yu W, Yzer S, et al. The clinical spectrum of polypoidal choroidal vasculopathy in white patients: a retrospective multicenter cohort study. Ophthalmol Retina. 2025;9:994\u20131004. https:\/\/doi.org\/10.1016\/j.oret.2025.04.019.","journal-title":"Ophthalmol Retina"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04827-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04827-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04827-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:08:55Z","timestamp":1794413335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04827-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":54,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4827"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04827-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing interests, financial disclosures, or personal relationships that could potentially influence the objectivity or integrity of this research.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The data collection process strictly adhered to the principles of the Declaration of Helsinki. The Institutional Review Board of Zhongshan Ophthalmic Center granted its approval for the study (2022KYPJ117 and 2023KYPJ114) and written informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}